Buy Adaptimmune Therapeutics Stock | ADAP Stock Price & Latest News | Public
ADAP

Adaptimmune Therapeutics

$0.00 (0.00%)Today

    About ADAP

    Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by B...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.17
    -0.25
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.23

    Actual EPS
    Q4 2020

    Stats

    Market Cap$665,04M
    Volume148,09k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$13.40
    1 Year Low$0.71
    Open$4.36
    High$5.15
    Low$4.29

    Buy any stock with any amount of money.

    Download the App
    Download the app